Skip to main content
. 2022 Oct 25;10(11):1793. doi: 10.3390/vaccines10111793

Table 2.

Descriptive analysis.

Variable Frequency
Sex M 810 (53.1%)
F 711 (46.6%)
Not specified 5 (0.3%)
Age 24–29 87 (5.6%)
30–64 901 (59.1%)
>65 538 (35.3%)
Cohabitation Not cohabitant 399 (26.2%)
Cohabitant 1099 (72.0%)
Not specified 28 (1.,8%)
Level of education Master’s degree 441 (28.9%)
Specialization or PhD 1085 (71.1%)
Health profession Physician 1363 (89.3%)
Dentist 163 (10.7%)
Work setting Hospital 340 (22.3%)
Teaching hospital 188 (12.3%)
Specialist outpatient clinic 120 (7.9%)
Private activity 620 (40.6%)
General practice 163 (10.7%)
Public health district 129 (8.45%)
Extended care 534 (2.2%)
Home care 28 (1.8%)
Outpatient first aid 12 (0.80%)
Research institution 42 (2.75%)
Other 211 (13.8%)
Work department (physicians) Medicine 605 (39.3%)
Surgery 194 (12.6%)
Diagnosis and Therapy 190 (12.4%)
Public health 173 (11.2%)
General Practice 149 (9.7%)
Other 228 (14.8%)
Chronic diseases Yes 541 (35.4%)
No 985 (64.6%)
Previous SARS-CoV-2 infection Yes, asymptomatic 26 (1.7%)
Yes, mild–moderate symptoms 106 (6.9%)
Yes, severe symptoms and hospitalization 16 (1.1%)
No 1378 (90.3%)